Do you want to be held hostage by your paycheck for the

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone fitzkarz #31570
Do you want to be held hostage
by your paycheck for the rest of your life? Didn't think so. That's why Professor Cramer dives into the first item on his syllabus: saving.



"My ultimate goal on this show is to teach you how to become better at managing your money—not just investment, but every aspect of your financial life," he said.

The first step? Start by saving 15 percent of your paycheck, or 10 percent if you can afford to, he says.

Start by putting half to two-thirds of your savings into a retirement account, such as a 401(k) or Individual Retirement Account (IRA). Those are tax-favored vehicles that you only pay tax when you withdraw the money at retirement.

Read MoreCramer basics: How to save, save, save

Okay, so you have saved your money like Jim Cramer recommended and you followed his advice to split it between a conservative retirement portfolio and a more aggressive discretionary Mad Money account.

Now what the heck do you do?

Cramer believes that a diversified portfolio of five to 10 individual stocks is the best way to go.

To start to pick individual stocks, you need to read the company's SEC filings. Most important the annual report, known as the 10-K, and the latest quarterly report, called the 10-Q.

It all comes down to doing your research. Additionally, check out the company's sector and try to figure out of this is a good time in the business cycle to own the stock, and compare it to the competition



The reality is that money is really important. It can ruin your life and relationships at the drop of a hat. Or even the drop of a stock valuation.

Speaking of which, what the heck does valuation mean? How do you know the difference between something that is cheap or expensive? Professor Cramer is here to explain.

First, never judge a stock by its dollar price. Judge it only by its price to earnings multiple, or P/E.

Don't worry—you don't need a fancy college degree, or even know how to do math. Simple elementary school arithmetic will allow you to calculate the P/E.

The price of a stock (P), divided by its earnings per share (E), equals the price to earnings multiple (M).

Valuations are all about the future, not the past. That is why Cramer always looks at the earnings estimates for next year when he evaluates a company.

"My rule of thumb…is that I don't like to pay more than two times a company's growth rate for a given stock, meaning any stock with a PEG ratio of more than 2 is pricey," said Cramer.

Read MoreCramer basics: How to value your portfolio

Now that you know how to pick the stocks in your portfolio, there is something else you should have in your portfolio; cash. Cash is that fuel that will let you buy stocks when there is a weakness, because you can't buy low if your cash is tied up in the market.

"Before we get into the actual amount of cash you should have at the ready, let me just make one thing crystal clear: You should always have SOME cash in your portfolio," said Cramer.

In fact, Cramer considers not having cash in your portfolio a reckless act. And don't even think about borrowing money to buy stocks on margin. Don't make that foolish mistake even though many brokers encourage you to do so.

How much cash do you leave? Well, it varies.

"I will say this: for my charitable trust … I like to keep my cash position above 5 percent of the portfolio at pretty much all times. Anything below 5 percent and I feel like the trust might as well be running on empty," said Cramer.

Essentially, the higher the stock market goes, the more cash you should keep on the sidelines. Remember that the reason you need the cash in the first place is to be in a good position on the next pull back. So even if this is counterintuitive, the mentality of buy low and sell high has never really gone out of style.

Now that you know how to save, invest, value and diversify your portfolio there is always Uncle Sam to deal with. The fact of the matter is that there is a lot you can do to minimize the damage on tax day.

Cramer recommends that you take every deduction you can legally get away with. That means knowing the difference between a short-term and long-term capital gains.

If you buy a stock and then sell it less than a year later, your profits will count as a short-term capital gain and are taxed at the ordinary income rate. That can be up to 39.6 percent. Yikes.

However if you hold a stock for over a year and then sell it, this is considered a long-term capital gain. That can be anywhere from 15 to 20 percent under the Obama regime. If you are in a higher tax bracket there is a 3.8 surtax that you pay on whatever is smaller, but that's still a heck of a lot less than the short-term tax rate.

"When you're investing in stocks, just tell yourself what I used to tell myself at my old hedge fund: it's okay to pay the tax man. It's a sin to give up your gains."

Now that you have the education to be an investor, go out there and make Cramer proud and make some mad money.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 0

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 0

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 1

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 0

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
TomoIQ Unveils Money Finder at Money20/20 Event

Updated Category News Views 0

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 0

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Jovani's Innovative Approach to Affordable Sustainable Fashion

Updated Category News Views 253

Understanding Gen Z's Fashion Preferences Young consumers today are navigating a complex landscape of fashion choices, often caught between the desire for quality and the struggle with affordability. A recent trend highlights this dilemma within Generation Z, where the majority prioritize sustainability but consistently return to fast fashion options due to lower prices....

Continue Reading
Steve Cohen Shifts Focus to Growth at Point72 Asset Management

Updated Category News Views 217

Steve Cohen's New Direction at Point72 Asset Management In a major development reported by Bloomberg News, billionaire Steve Cohen, founder of Point72 Asset Management, has made the notable decision to step back from active trading. This strategic change aims to bolster the firm's growth trajectory and adapt to the shifting landscape of asset management. Mentoring Future...

Continue Reading
Opportunity for Methode Electronics, Inc. Investors to Join Class Action

Updated Category News Views 125

Class Action Lawsuit Filed for Methode Electronics, Inc. Investors Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm specializing in investor rights, has announced that a class action lawsuit has been filed against Methode Electronics, Inc. (NYSE: MEI) and its management team. This lawsuit is particularly important for investors who may have experienced...

Continue Reading
NORBIT ASA Proposes NOK 3.00 Dividend for 2024 Fiscal Year

Updated Category News Views 268

NORBIT ASA Announces Proposed Cash Dividend NORBIT ASA has made an important announcement regarding the proposed cash dividend to be paid to its shareholders. As part of their ongoing commitment to return value to investors, the board of directors has put forth a resolution suggesting a dividend of NOK 3.00 per share for the fiscal year 2024. This proposal will be...

Continue Reading
Settlement Reached for Pilgrim's Pride Corporation Investors

Updated Category News Views 311

Understanding the Proposed Settlement for Pilgrim's Pride Corporation A notable development has emerged regarding the Pilgrim's Pride Corporation and its securities, which will impact everyone who has bought or otherwise acquired shares in the company. A proposed settlement has been announced, aiming to provide clarity and potential compensation for affected investors....

Continue Reading